System-based approaches to decode the molecular links in Parkinson's disease and diabetes
A growing body of evidence indicates an increased risk for developing Parkinson's disease (PD) among people with type 2 diabetes (T2DM). The relationship between the etiology and development of both chronic diseases is beginning to be uncovered and recent studies show that PD and T2DM share rem...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-12-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996114000801 |
id |
doaj-76aba73f4d184316a59bc7df520c4fb9 |
---|---|
record_format |
Article |
spelling |
doaj-76aba73f4d184316a59bc7df520c4fb92021-03-22T12:41:08ZengElsevierNeurobiology of Disease1095-953X2014-12-01728491System-based approaches to decode the molecular links in Parkinson's disease and diabetesJose A. Santiago0Judith A. Potashkin1The Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USACorresponding author at: Department of Cellular and Molecular Pharmacology, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.; The Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USAA growing body of evidence indicates an increased risk for developing Parkinson's disease (PD) among people with type 2 diabetes (T2DM). The relationship between the etiology and development of both chronic diseases is beginning to be uncovered and recent studies show that PD and T2DM share remarkably similar dysregulated pathways. It has been proposed that a cascade of events including mitochondrial dysfunction, impaired insulin signaling, and metabolic inflammation trigger neurodegeneration in T2DM models. Network-based approaches have elucidated a potential molecular framework linking both diseases. Further, transcriptional signatures that modulate the neurodegenerative phenotype in T2DM have been identified. Here we contextualize the current experimental approaches to dissect the mechanisms underlying the association between PD and T2DM and discuss the existing challenges toward the understanding of the coexistence of these devastating aging diseases.http://www.sciencedirect.com/science/article/pii/S0969996114000801Parkinson's diseaseType 2 diabetesNeurodegenerationInflammationInsulin resistance |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jose A. Santiago Judith A. Potashkin |
spellingShingle |
Jose A. Santiago Judith A. Potashkin System-based approaches to decode the molecular links in Parkinson's disease and diabetes Neurobiology of Disease Parkinson's disease Type 2 diabetes Neurodegeneration Inflammation Insulin resistance |
author_facet |
Jose A. Santiago Judith A. Potashkin |
author_sort |
Jose A. Santiago |
title |
System-based approaches to decode the molecular links in Parkinson's disease and diabetes |
title_short |
System-based approaches to decode the molecular links in Parkinson's disease and diabetes |
title_full |
System-based approaches to decode the molecular links in Parkinson's disease and diabetes |
title_fullStr |
System-based approaches to decode the molecular links in Parkinson's disease and diabetes |
title_full_unstemmed |
System-based approaches to decode the molecular links in Parkinson's disease and diabetes |
title_sort |
system-based approaches to decode the molecular links in parkinson's disease and diabetes |
publisher |
Elsevier |
series |
Neurobiology of Disease |
issn |
1095-953X |
publishDate |
2014-12-01 |
description |
A growing body of evidence indicates an increased risk for developing Parkinson's disease (PD) among people with type 2 diabetes (T2DM). The relationship between the etiology and development of both chronic diseases is beginning to be uncovered and recent studies show that PD and T2DM share remarkably similar dysregulated pathways. It has been proposed that a cascade of events including mitochondrial dysfunction, impaired insulin signaling, and metabolic inflammation trigger neurodegeneration in T2DM models. Network-based approaches have elucidated a potential molecular framework linking both diseases. Further, transcriptional signatures that modulate the neurodegenerative phenotype in T2DM have been identified. Here we contextualize the current experimental approaches to dissect the mechanisms underlying the association between PD and T2DM and discuss the existing challenges toward the understanding of the coexistence of these devastating aging diseases. |
topic |
Parkinson's disease Type 2 diabetes Neurodegeneration Inflammation Insulin resistance |
url |
http://www.sciencedirect.com/science/article/pii/S0969996114000801 |
work_keys_str_mv |
AT joseasantiago systembasedapproachestodecodethemolecularlinksinparkinsonsdiseaseanddiabetes AT judithapotashkin systembasedapproachestodecodethemolecularlinksinparkinsonsdiseaseanddiabetes |
_version_ |
1724208356153884672 |